The short answer
A bleeding interaction between ginger root powder and heparin has not been established. Human powdered-ginger studies have mixed platelet findings, including null results, and do not provide a universal avoidance or spacing rule.
What this answer covers
Zingiber officinale dried rhizome powder, commonly sold as root powder; not fresh juice, oil or a concentrated extract. Heparin means injected unfractionated heparin.
- Supplement or preparation
- Zingiber Officinale (Ginger) Root Powder
- Medication ingredient
- heparin
Some powder studies found no effect
Eight healthy men took a single 2 g dried-ginger dose or placebo, with no difference in bleeding time or measured platelet tests. Another study found no platelet-aggregation change with 4 g/day powdered ginger for three months. Neither establishes safety during heparin treatment.
A higher single dose changed a surrogate
The latter study found reduced platelet aggregation after a separate 10 g single dose. That is a laboratory response rather than proof of clinical bleeding or a heparin interaction. The contrast does not define a safe dose threshold.
Current monograph and preparation limits
The European ginger monograph lists no known interactions for its covered preparations. This does not mean heparin co-use was tested. Evidence from powder should not be silently transferred to extracts or fresh ginger, and the actual botanical preparation remains important.
No established spacing solution
Tell the heparin team about the exact supplement before starting or changing it. Report unusual bleeding or bruising promptly; serious bleeding, black stools or vomiting blood needs urgent assessment. Do not change prescribed heparin yourself. No reviewed evidence establishes a universal stop rule or a protective interval between ginger powder and heparin.
Evidence and practical considerations
Timing & monitoring
No established universal avoidance or protective spacing; covered-product monograph reports no known interactions.
- Exact scope
- Zingiber officinale dried rhizome powder, commonly sold as root powder; not fresh juice, oil or a concentrated extract. Heparin means injected unfractionated heparin. with Unfractionated heparin sodium intravenous/subcutaneous, active-ingredient bridge to RxCUI5224 IN. Not LMWH or topical therapy.
- Medication form and route
- intravenous or subcutaneous unfractionated heparin; oral supplement
What remains uncertain
- No universal risk estimate, dose adjustment or spacing interval; source-specific limits apply.
Factors that may matter: Exact product; Dose/duration; Other antithrombotics; Bleeding risk; Kidney function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People receiving parenteral unfractionated heparin.
Heparin can cause hemorrhage; medicines inhibiting platelets can add bleeding concerns. Aldosterone suppression can cause hyperkalemia, especially with predisposing conditions or potassium-sparing medicines. Heparin is not absorbed through the gastrointestinal tract.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
No botanical interaction specifically named. Not low-molecular-weight heparin, topical heparin cream or an oral anticoagulant; doses and risks of catheter flush products are not automatically equivalent.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Eight healthy men.
No difference in bleeding time, platelet count, thromboelastography or aggregation versus placebo.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
Eight volunteers, no heparin; short surrogate study cannot establish long-term safety or a safe dose threshold.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Coronary artery disease participants; subgroup counts absent from abstract.
Powdered ginger4g/day for three months did not change platelet aggregation; a separate10g single dose reduced aggregation.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
Clinical bleeding and exact heparin co-use not established in abstract; dose-dependent surrogate findings do not set a safe supplement dose.
Source 4: regulatory herbal monograph
ema.europa.eu · Source check Sep 10, 2026
Population: Users of the specified preparation.
No known interactions listed for covered preparations.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
No known interaction is not evidence of tested heparin safety; commercial name root powder refers to rhizome material and must be confirmed.
Research assessment: · Open full citations ↗
Side effects & toxicity
Mixed powder platelet surrogates without heparin or clinical bleeding outcomes cannot establish this exact-pair bleeding claim.
- Exact scope
- Zingiber officinale dried rhizome powder, commonly sold as root powder; not fresh juice, oil or a concentrated extract. Heparin means injected unfractionated heparin. with Unfractionated heparin sodium intravenous/subcutaneous, active-ingredient bridge to RxCUI5224 IN. Not LMWH or topical therapy.
- Medication form and route
- intravenous or subcutaneous unfractionated heparin; oral supplement
What remains uncertain
- No universal risk estimate, dose adjustment or spacing interval; source-specific limits apply.
Factors that may matter: Exact product; Dose/duration; Other antithrombotics; Bleeding risk; Kidney function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People receiving parenteral unfractionated heparin.
Heparin can cause hemorrhage; medicines inhibiting platelets can add bleeding concerns. Aldosterone suppression can cause hyperkalemia, especially with predisposing conditions or potassium-sparing medicines. Heparin is not absorbed through the gastrointestinal tract.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
No botanical interaction specifically named. Not low-molecular-weight heparin, topical heparin cream or an oral anticoagulant; doses and risks of catheter flush products are not automatically equivalent.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Eight healthy men.
No difference in bleeding time, platelet count, thromboelastography or aggregation versus placebo.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
Eight volunteers, no heparin; short surrogate study cannot establish long-term safety or a safe dose threshold.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Coronary artery disease participants; subgroup counts absent from abstract.
Powdered ginger4g/day for three months did not change platelet aggregation; a separate10g single dose reduced aggregation.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
Clinical bleeding and exact heparin co-use not established in abstract; dose-dependent surrogate findings do not set a safe supplement dose.
Source 4: regulatory herbal monograph
ema.europa.eu · Source check Sep 10, 2026
Population: Users of the specified preparation.
No known interactions listed for covered preparations.
How this applies: Exact species, preparation, route and measured endpoints govern applicability; other anticoagulants are not silently treated as heparin.
No known interaction is not evidence of tested heparin safety; commercial name root powder refers to rhizome material and must be confirmed.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact-pair article preserving route, formulation, clinical-outcome and laboratory-endpoint distinctions. | |
| Research summary published |
Article revision: 96d0d119075fa870
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.